Literature DB >> 33632127

Comparison of the effectiveness of position change for patients with pain and vascular complications after transfemoral coronary angiography: a randomized clinical trial.

Hojjat Niknam Sarabi1, Zahra Farsi2, Samantha Butler3, Amir Hosein Pishgooie4.   

Abstract

BACKGROUND: Prolonged immobilization after transfemoral coronary angiography (TFA) may cause pain and vascular complications in patients. This study aimed to evaluate the effectiveness of a change in position to decrease pain and vascular complications for patients after TFA.
METHODS: This randomized clinical trial was conducted in 2020. Purposive sampling of 72 eligible patients undergoing TFA were selected and randomly assigned to either an experimental or control group. Patients in the experimental group (EG) were placed in a supine position for 2 h after angiography, followed by a semi-seated position with the bed angle gradually increased to 45° over 4 h. Patients in the control group (CG) remained in the supine position for 6 h. Vital signs, groin, back and leg pain, hematoma, hemorrhage, and urinary retention were assessed in both groups before, immediately after, and over 6 h after angiography. The Visual Analogue Scale was used to measure pain, the Christensen scale to measure hematoma, counting bloody gases to measure hemorrhage, and patient self-rating to determine urinary retention.
RESULTS: There was no significant difference between EG and CG on score of groin (2.69 ± 1.00 vs. 2.61 ± 1.00, P = 0.74), back (2.19 ± 0.98 vs. 2.47 ± 0.87, P = 0.21), and leg pain (2.14 ± 0.71 vs. 2.50 ± 1.08, P = 0.27) before the TFA. However, from the second hour to the sixth hour after the TFA, the pain in the EG was significantly less than the CG (P < 0.001). So that pain in the groin (1.36 ± 0.48 vs. 3.28 ± 0.81), back (1.25 ± 0.50 vs. 3.81 ± 1.06), and leg (1.44 ± 0.55 vs. 3.28 ± 0.81) for the EG patients was significantly less than the CG in the sixth hour after TFA (P < 0.001). No patients experienced hematoma. No differences were noted between groups in hemorrhage and urinary retention.
CONCLUSIONS: Position change to a semi-seated position in patients after TFA is effective and safe for reduction of pain without increasing vascular complications. TRIAL REGISTRATION: Iranian Registry of Clinical Trials: IRCT registration number: IRCT20200410047011N1, Registration date: 30/04/2020.

Entities:  

Keywords:  Cardiac catheterization; Coronary angiography; Hematoma; Hemorrhage; Pain

Year:  2021        PMID: 33632127     DOI: 10.1186/s12872-021-01922-w

Source DB:  PubMed          Journal:  BMC Cardiovasc Disord        ISSN: 1471-2261            Impact factor:   2.298


  20 in total

1.  Predictors of complications following sheath removal with percutaneous coronary intervention.

Authors:  Linda M Sulzbach-Hoke; Sarah J Ratcliffe; Stephen E Kimmel; Daniel M Kolansky; Rosemary Polomano
Journal:  J Cardiovasc Nurs       Date:  2010 May-Jun       Impact factor: 2.083

2.  The effects of foot reflexology on back pain after coronary angiography: A randomized controlled trial.

Authors:  Mojgan Kardan; Bahare Zarei; Hamidreza BahramiTaghanaki; Seyyed Abolfazl Vagharseyyedin; Nahid Azdaki
Journal:  Complement Ther Clin Pract       Date:  2019-11-08       Impact factor: 2.446

3.  Effect of positioning on patient outcomes after coronary angiography: a single-blind randomized controlled trial.

Authors:  Fateme Bakhshi; Zahra Namjou; Abbas Andishmand; Aliasghar Panabadi; Mostafa Bagherinasab; Mohammadtaghi Sarebanhassanabadi
Journal:  J Nurs Res       Date:  2014-03       Impact factor: 1.682

4.  Modeling the Burden of Cardiovascular Diseases in Iran from 2005 to 2025: The Impact of Demographic Changes.

Authors:  Masoumeh Sadeghi; Ali Akbar Haghdoost; Abbas Bahrampour; Mohsen Dehghani
Journal:  Iran J Public Health       Date:  2017-04       Impact factor: 1.429

Review 5.  Transradial vs. Transfemoral Approach in Cardiac Catheterization: A Literature Review.

Authors:  Ibrar Anjum; Muhammad Adnan Khan; Muhammad Aadil; Aniqa Faraz; Mudassir Farooqui; Amerah Hashmi
Journal:  Cureus       Date:  2017-06-03

Review 6.  The increasing prevalence of non-communicable diseases in low-middle income countries: the view from Malawi.

Authors:  Matthew Gowshall; Simon D Taylor-Robinson
Journal:  Int J Gen Med       Date:  2018-06-28

7.  The effect of the application of cold on hematoma, ecchymosis, and pain at the catheter site in patients undergoing percutaneous coronary intervention.

Authors:  Yeter Kurt; Mağfiret Kaşıkçı
Journal:  Int J Nurs Sci       Date:  2019-09-05

Review 8.  Meta-analysis of complication as a risk factor for early ambulation after percutaneous coronary intervention.

Authors:  Kyunghee Kim; Sungho Won; Jisu Kim; Eunkyung Lee; Kisook Kim; Suyeon Park
Journal:  Eur J Cardiovasc Nurs       Date:  2012-10-17       Impact factor: 3.908

9.  Prevalence of coronary artery disease risk factors in Iran: a population based survey.

Authors:  Z N Hatmi; S Tahvildari; A Gafarzadeh Motlag; A Sabouri Kashani
Journal:  BMC Cardiovasc Disord       Date:  2007-10-30       Impact factor: 2.298

Review 10.  Risks and complications of coronary angiography: a comprehensive review.

Authors:  Morteza Tavakol; Salman Ashraf; Sorin J Brener
Journal:  Glob J Health Sci       Date:  2012-01-01
View more
  2 in total

1.  The Efficacy of an Intervention Program for Pain Intensity Reduction in Patients Undergoing Arterial Sheath Removal after Coronary Artery Angioplasty.

Authors:  Esmail Heidaranlu; Naser Sedghi Goyaghaj; Ali Moradi; Abbas Ebadi
Journal:  J Tehran Heart Cent       Date:  2021-07

2.  Music-induced analgesia for adults and older adults during femoral arterial sheath removal after cardiac catheterization: a randomized clinical trial protocol.

Authors:  Kauanny Vitoria Gurgel Dos Santos; Karena Cristina da Silva Leal; Louise Constancia de Melo Alves Silva; Kleyton Santos de Medeiros; Alexsandra Rodrigues Feijão; Maria do Carmo de Oliveira; Daniele Vieira Dantas; Rodrigo Assis Neves Dantas
Journal:  BMC Complement Med Ther       Date:  2022-09-19
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.